Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

Publication | Open Access

DOI Full Paper Access

152

Citations

References

2021

Year

Shahin Lockman, Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean‐Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie,

The Lancet

Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyGynecologyMaternal HealthTenofovir Alafenamide FumaratePharmacotherapyAntiviral DrugHivMedicinePhase 3Impaact 2010/Vested